Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Ascendis Pharma AS | 16 |
| 2 | Henkel AG and Co KGaA | 5 |
| 3 | Colorado State University System | 4 |
| 4 | Harvard University | 4 |
| 5 | Corteva Inc | 3 |
| 6 | Ginkgo Bioworks Holdings Inc | 3 |
| 7 | MerLion Pharmaceuticals GmbH | 3 |
| 8 | University of Minnesota System | 3 |
| 9 | BASF SE | 2 |
| 10 | Eli Lilly and Co | 2 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 77 |
| 2 | A61K | Medicinal preparations | 50 |
| 3 | C12P | Fermentation, enzyme processes | 47 |
| 4 | C07K | Peptides | 42 |
| 5 | Y02E | Climate change mitigation: energy | 42 |
| 6 | C12Y | Enzyme nomenclature (EC numbers) | 33 |
| 7 | Y02P | Climate change mitigation: production | 18 |
| 8 | A61P | Therapeutic activity (drug indications) | 17 |
| 9 | G01N | Investigating / analysing materials | 17 |
| 10 | C07C | Acyclic and carbocyclic compounds | 14 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS | 2011 | Ascendis Pharma AS | 176 |
| HYDROGEL PRODRUGS | 2014 | Ascendis Pharma AS | 64 |
| Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | 2017 | 42 | |
| Selected polynucleotide and polypeptide sequences of the methanogenic archaeon, methanococcus jannashii | 2003 | J Craig Venter Institute Inc | 52 |
| Compositions, apparatus, systems, and methods for resolving electronic excited states | 2015 | 18 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Mary E. Lidstrom | University of Washington | 8 |
| 2 | Julia A. Vorholt | Max Planck Institute for Terrestrial Microbiology | 7 |
| 3 | Rudolf K. Thauer | Max Planck Institute for Terrestrial Microbiology | 6 |
| 4 | Ludmila Chistoserdova | University of Washington | 6 |
| 5 | Christopher J. Marx | University of Washington | 5 |
| 6 | R. S. Wolfe | University of Illinois Urbana-Champaign | 4 |
| 7 | Ulrich Ermler | Max Planck Institute of Biophysics | 3 |
| 8 | Marina Kalyuzhnaya | University of Washington | 3 |
| 9 | Seigo Shima | Max Planck Institute for Terrestrial Microbiology | 2 |
| 10 | Olivier Nercessian | University of Washington | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Tetrahydrofolate and tetrahydromethanopterin compared: functionally distinct carriers in C1 metabolism | 2000 | 211 | Metabolism and Genetic Disorders |
| Novel Formaldehyde-Activating Enzyme in Methylobacterium extorquens AM1 Required for Growth on Methanol | 2000 | 187 | Alcohol Consumption and Health Effects |
| Tetrahydromethanopterin, a carbon carrier in methanogenesis. | 1984 | 151 | Metabolism and Genetic Disorders |
| Formaldehyde-Detoxifying Role of theTetrahydromethanopterin-Linked Pathway in Methylobacteriumextorquens AM1 | 2003 | 138 | Metabolism and Genetic Disorders |
| An archaeal origin of the Wood–Ljungdahl H4MPT branch and the emergence of bacterial methylotrophy | 2019 | 79 | Porphyrin Metabolism and Disorders |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and molecular weight of tetrahydromethanopterin?
Which organizations hold the most patents related to tetrahydromethanopterin?
What are the primary research areas covered by patents related to this compound?
Who are the leading academic researchers publishing on tetrahydromethanopterin?
How has patent activity around tetrahydromethanopterin changed over recent years?